INTRODUCTION
Testosterone given with oestrogen to progesterone-primed ovariectomized ewes has a dual action (Lindsay & Robinson, 1964) . Oestrogen-induced behavioural oestrus is augmented by the testosterone but the normal vaginal smear response (Robinson & Moore, 1956 ) is virtually eliminated. Thus testosterone is an antioestrogen when evaluated by the vaginal response, but is an oestrogen when oestrous behaviour is the parameter.
Since the work of Allen & Doisy (1923) , which showed the relationship between vaginal epithelial cornification and oestrus in rodents, little attention has been paid to the presence of overt oestrus in studies of hormone interactions in laboratory animals. Other parameters have been used to assess anti-oestrogenic activity, such as uterine weight response (Velardo, 1959;  Edgren, Calhoun, Elton & Colton, 1959;  Dorfman, Kind & Ringold, 1961a, 6 ) and the more sensitive tetrazolium reduction and vaginal mitotic frequency tests of Martin (1960) . However, where comparison is possible among various assays, it is clear that the relative potencies or, in some cases, the absolute actions of the substances vary greatly according to the parameter chosen and the species used. For example, Emmens, Cox & Martin (1959) reported that progesterone and androgens which suppress oestrogen-induced vaginal cornification in mice "do not prevent mitosis and proliferation in the oestrogenstimulated vagina in ratios of up to a million to one (L. Martin 17/?-Acetoxy-5a-androst-l-en-3-one 17/?-Hydroxy-17<x-methyl-5<x-androst-l-en-3-one 17/?-Ethyl-17a-hydroxy-19-norandrost-4-en-3-one 17/?-Acetoxy-17a-ethynyloestr-4-en-3/?-ol 3/?-Acetoxy-17a-methyl-5a-androst-1-en-17/?-ol Androst-4-ene-3,l 7-dione 17a-Hydroxy-17/?-methyl-2-oxa-5a-androstan-3-one 17/?-Hydroxy-17a-isobutenyloestr-4-en-3-one Zß-Acetoxy-17a-isobutenyloestr-4-en-17/S-ol 3/S,17/?-Propionoxy-oestr-4-ene 17/î-Hydroxy-17a-methyloestr-5( 10)en-3-one 17/?-Hydroxyoestr-4-en-3-one 3/5-Propionoxy-19-nor-pregn-4-en-17a-ol 3/î-Acetoxy-17oe-ethynyloestr-4-en-17/S-ol (Reardon, 1959 chosen without knowledge of their action, but in the cases of several substances approximate estimates of their relative potencies could be made. Thus SC-7992, SC-11195, SC-11464, SC-9394, SC-9022, SC-11462 and SC-7294 appeared to inhibit behavioural oestrus at doses of 2-5 to 10-0 mg. and were largely ineffective below 2-5 mg. The dose of androstenedione necessary to augment behavioural responses appeared to be somewhat less than this. Augmentation of vaginal oestrus by was obtained at a dose between 2-5 and 10-0 mg. (Emmens, Cox & Martin, 1960) and the rat (Edgren, 1957) (Emmens, 1965) . Two others, SC-11195 and SC-11464, had similar anti-oestrogenic effects in both species while another, SC-5888, was inactive in both species (Emmens, 1965) . Thus, it is probable that the involvement of steroids in the chemical pathways leading to the production of positive vaginal smears, and possibly of overt oestrus, differs in the ewe and the mouse.
The augmentation of oestrogen-induced behavioural oestrus by androstenedione is similar to that by testosterone, in that vaginal oestrus is also inhibited (Lindsay & Robinson, 1964) . Its behavioural effect may be due to a direct action on reacting neurones or to pro-oestrogenic activity after conversion to oestrogen or testosterone. Androstenedione appears to be an intermediary metabolite in the biosynthesis of both of these hormones (Short, 1962a, b; Lindner, 1961) . Robinson & Brander (1962) suggest that substances with pro-oestrogenic activity may not be active by the intravenous route which indicates that androstenedione may be acting as a true oestrogen in its behavioural effect. At the same time its activity when measured by the vaginal smear technique is anti-oestrogenic and, apart from having a con¬ siderably higher median effective dose, it appears to be functionally indistinguishable from testosterone.
